|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3950 EUR | -1.74% |
|
+3.40% | +32.55% |
| 07-01 | Nicox Submits NCX 470 New Drug Application In The United States | CI |
| 07-01 | Nicox files U.S. marketing approval application |  |
Evolution of the Average Target: Nicox SA
Evolution of the Target Price: Nicox SA
Changes in Analyst Recommendations: Nicox SA
b676921422bfcb.rZPDHy541BPiYJK2DDoW65zl-LkPB1R68l3NZUioOtU.6v6WR2IUv0eKFfn7RFtug9iJzos4dDhJim6qJCrGYKXBpLFlX1WTRZU1og~fcdffc3ca46e506227816f06556457d5
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +148.76% | |||
| +5.96% | |||||
| +2.69% | |||||
| +5.61% | |||||
| -10.74% | |||||
| +71.56% | |||||
| +70.67% | |||||
| - | - | -23.31% | |||
| +35.87% | |||||
| Average | +34.12% | |||||
| Weighted average by Cap. | +6.29% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3950EUR
Average target price
1.000EUR
Spread / Average Target
+153.16%
High Price Target
1.000EUR
Spread / Highest target
+153.16%
Low Price Target
1.000EUR
Spread / Lowest Target
+153.16%
Analyst Consensus Detail
Consensus revision (last 18 months)
SellBuy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3950EUR
Average target price
1.000EUR
Spread / Average Target
+153.16%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALCOX Stock
- Consensus Nicox SA
Select your edition
All financial news and data tailored to specific country editions
